이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
West Pharmaceutical Services 관리
관리 기준 확인 4/4
West Pharmaceutical Services' CEO는 Eric Green, Apr2015 에 임명되었습니다 의 임기는 9.17 년입니다. 총 연간 보상은 $ 9.40M, 12.1% 로 구성됩니다. 12.1% 급여 및 87.9% 보너스(회사 주식 및 옵션 포함). 는 $ 52.15M 가치에 해당하는 회사 주식의 0.22% 직접 소유합니다. 52.15M. 경영진과 이사회의 평균 재임 기간은 각각 4.6 년과 9.1 년입니다.
주요 정보
Eric Green
최고 경영자
US$9.4m
총 보상
| CEO 급여 비율 | 12.1% |
| CEO 임기 | 9.4yrs |
| CEO 소유권 | 0.2% |
| 경영진 평균 재임 기간 | 4.3yrs |
| 이사회 평균 재임 기간 | 9.3yrs |
최근 관리 업데이트
Recent updates
Getting In Cheap On West Pharmaceutical Services, Inc. (NYSE:WST) Is Unlikely
Sep 20
A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST)
Sep 02West Pharmaceutical Services, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Jul 28West Pharmaceutical: Continued Destocking And A High Valuation Post Q2 Results (Rating Maintained)
Jul 25Is It Time To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?
Jul 15We Think West Pharmaceutical Services (NYSE:WST) Can Stay On Top Of Its Debt
Jun 27Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)
May 21West Pharmaceutical: Pick And Shovels Of The Injectable Drug Industry
May 11West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price
Mar 30Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?
Mar 12Why West Pharma Is Far From Done
Feb 28West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price
Feb 20West Pharmaceutical Services: Still Too Expensive After The Recent Drop
Feb 20What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?
Jan 10West Pharmaceutical: Great Business, Not So Great Valuation
Jan 08What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You
Dec 18West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Nov 27West Pharmaceutical Services: The Run Might Be Over
Oct 18Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?
Sep 24Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
Aug 22West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics
Aug 08What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?
Jun 26West Pharmaceutical: Hard To Justify The Price
May 26Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
May 16At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?
Mar 20West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture
Feb 28West Pharmaceutical Q4 2022 Earnings Preview
Feb 15West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Jan 31West Pharmaceutical: An Earnings Decline Seen In 2023, Shares Still Appear Expensive
Dec 19West Pharmaceutical declares $0.19 dividend
Dec 13Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching
Nov 29West Pharmaceutical Q3 2022 Earnings Preview
Oct 26West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly
Oct 25West Pharmaceutical Services: Shares Need To Get Cheaper To Make Sense
Oct 02CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$525m |
| Mar 31 2024 | n/a | n/a | US$569m |
| Dec 31 2023 | US$9m | US$1m | US$593m |
| Sep 30 2023 | n/a | n/a | US$559m |
| Jun 30 2023 | n/a | n/a | US$519m |
| Mar 31 2023 | n/a | n/a | US$552m |
| Dec 31 2022 | US$8m | US$1m | US$586m |
| Sep 30 2022 | n/a | n/a | US$631m |
| Jun 30 2022 | n/a | n/a | US$686m |
| Mar 31 2022 | n/a | n/a | US$684m |
| Dec 31 2021 | US$9m | US$1m | US$662m |
| Sep 30 2021 | n/a | n/a | US$613m |
| Jun 30 2021 | n/a | n/a | US$519m |
| Mar 31 2021 | n/a | n/a | US$423m |
| Dec 31 2020 | US$8m | US$989k | US$346m |
| Sep 30 2020 | n/a | n/a | US$312m |
| Jun 30 2020 | n/a | n/a | US$286m |
| Mar 31 2020 | n/a | n/a | US$261m |
| Dec 31 2019 | US$7m | US$936k | US$242m |
| Sep 30 2019 | n/a | n/a | US$230m |
| Jun 30 2019 | n/a | n/a | US$229m |
| Mar 31 2019 | n/a | n/a | US$219m |
| Dec 31 2018 | US$5m | US$880k | US$207m |
| Sep 30 2018 | n/a | n/a | US$155m |
| Jun 30 2018 | n/a | n/a | US$151m |
| Mar 31 2018 | n/a | n/a | US$133m |
| Dec 31 2017 | US$5m | US$824k | US$151m |
보상 대 시장: Eric 의 총 보상 ($USD 9.40M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 13.41M ).
보상과 수익: Eric 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Eric Green (54 yo)
9.4yrs
테뉴어
US$9,395,896
보상
Mr. Eric M. Green serves as Independent Director at Ecolab Inc. since December 08, 2022. He has been the Chief Executive Officer of West Pharmaceutical Services, Inc. since April 24, 2015 and its President...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Non-Independent Chair of the Board | 9.4yrs | US$9.40m | 0.23% $ 52.2m | |
| Senior VP & CFO | 6.3yrs | US$3.64m | 0.0095% $ 2.1m | |
| Senior VP & CTO | 3.8yrs | US$1.67m | 0.0039% $ 888.9k | |
| Senior VP | 3.8yrs | US$1.49m | 0.0019% $ 421.9k | |
| Senior VP & Chief Commercial Officer | 4.8yrs | US$1.53m | 0.0067% $ 1.5m | |
| VP, Chief Accounting Officer & Corporate Controller | 4.9yrs | 데이터 없음 | 0.0018% $ 406.1k | |
| Head of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Vice President of Global Communications | no data | 데이터 없음 | 데이터 없음 | |
| Senior VP of Strategy & Corporate Development | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Human Resources Officer & Senior VP | 8.9yrs | US$1.14m | 0.0090% $ 2.0m | |
| Senior VP and Chief Quality & Regulatory Officer | 2.3yrs | 데이터 없음 | 데이터 없음 | |
| President of Contract Manufacturing | less than a year | 데이터 없음 | 데이터 없음 |
4.3yrs
평균 재임 기간
54yo
평균 연령
경험이 풍부한 관리: WST 의 관리팀은 경험 ( 4.6 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Non-Independent Chair of the Board | 9.3yrs | US$9.40m | 0.23% $ 52.2m | |
| Independent Director | 10.6yrs | US$359.35k | 0.024% $ 5.3m | |
| Independent Director | 4.6yrs | US$330.66k | 0.0034% $ 755.8k | |
| Independent Director | 16.9yrs | US$390.35k | 0.059% $ 13.4m | |
| Independent Director | 13.6yrs | US$378.23k | 0.056% $ 12.6m | |
| Independent Director | 13.6yrs | US$377.01k | 0.059% $ 13.3m | |
| Lead Independent Director | 8yrs | US$367.44k | 0.012% $ 2.7m | |
| Independent Director | 2.2yrs | US$331.46k | 0.0015% $ 333.9k | |
| Independent Director | 12.6yrs | US$362.83k | 0.040% $ 9.1m | |
| Independent Director | 7.3yrs | US$333.45k | 데이터 없음 | |
| Honorary Director | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 3.1yrs | US$321.43k | 0.00087% $ 196.3k |
9.3yrs
평균 재임 기간
63yo
평균 연령
경험이 풍부한 이사회: WST 의 이사회는 경험(평균 재직 기간 9.1 년)으로 간주됩니다.